
Lattice Therapeutics
Lattice Therapeutics: Pioneering non-viral, precision drug delivery for transformative gene therapy.
- 3
- Private company
- Washington, DC, USUnited States
Lattice Therapeutics aims to unlock the transformative potential of gene and nucleic acid therapy to cure and prevent diseases. It offers a next-generation, non-viral, precision drug delivery platform designed to drive life-changing medical outcomes. Founded in 2021, the company is based in Washington, DC.
Lattice Therapeutics has made significant strides in the biotech industry by developing innovative delivery systems that enhance the efficacy and safety of gene therapies. Its pioneering approach has garnered attention for its potential to revolutionize treatment methodologies.
Similar Companies

Intergalactic Therapeutics

Myosana Therapeutics

Luminary Therapeutics
luminarytx.com

Xalud Therapeutics
xaludthera.com
Dnalite Therapeutics

Piezo Therapeutics
piezotx.com

Code Biotherapeutics
codebiotx.com

Lacerta Therapeutics

Aera Therapeutics
aeratx.com

Atom Bioworks
atombioworks.com
Carigent Therapeutics

Enable Therapeutics

Beam Therapeutics
beamtx.com

Carmine Therapeutics

Ring Therapeutics
ringtx.com

Cytonus Therapeutics
cytonus.com

Nanite
nanitebio.com

Nuntius Therapeutics
nuntiustx.com

Latigo Biotherapeutics
latigobio.com

Nested Therapeutics
nestedtx.com
Quick Facts
Who are Lattice Therapeutics' competitors?
Companies similar to Lattice Therapeutics include Intergalactic Therapeutics, Myosana Therapeutics, Luminary Therapeutics and Xalud Therapeutics.
When was Lattice Therapeutics founded?
Lattice Therapeutics was founded in 2021.
Where is Lattice Therapeutics' headquarters located?
Lattice Therapeutics' headquarters is located in Washington, DC, US.
When was Lattice Therapeutics' last funding round?
Lattice Therapeutics' most recent funding round was for $300k (USD) in June 2022.
How much disclosed funding has Lattice Therapeutics raised?
As of Jun 13, 2022, Lattice Therapeutics has disclosed funding of $300k (USD). Undisclosed round amounts are excluded.
How many employees does Lattice Therapeutics have?
Lattice Therapeutics has 3 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Model
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified